Paper10580331
Regulation of mevalonate synthesis in low density lipoprotein receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids.
El-Sohemy A and 1 other. Lipids, 1999. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Regulation of mevalonate synthesis in low density lipoprotein receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids. Papers, record 10580331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10580331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulation of mevalonate synthesis in low density lipoprotein receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fatty Acids, Unsaturated | Major topic |
| Hydroxymethylglutaryl CoA Reductases | Major topic |
| Mevalonic Acid | Major topic |
| Receptors, LDL | Major topic |
| Animals | |
| Diet | |
| Female | |
| Liver | |
| Mice | |
| Mice, Knockout |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,967,820 | Regulation of the mevalonate pathway. | Nature | 1990 | https://conductscience.org/library/papers/1967820 | PubMed |
| 2 | 6,683,964 | Regulation of cholesterol synthesis in the liver and mammary gland of the lactating rat. | Biochem J | 1983 | https://conductscience.org/library/papers/6683964 | PubMed |
| 3 | 8,245,716 | Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. | J Lipid Res | 1993 | https://conductscience.org/library/papers/8245716 | PubMed |
| 4 | 1,423,585 | Koch's postulates for cholesterol. | Cell | 1992 | https://conductscience.org/library/papers/1423585 | PubMed |
| 5 | 9,328,167 | Anti-carcinogenic activity of simvastatin during the promotion phase of radiation-induced mammary tumorigenesis of rats. | Carcinogenesis | 1997 | https://conductscience.org/library/papers/9328167 | PubMed |
| 6 | 3,613,872 | Loss of NADPH during assays of HMG-CoA reductase: implications and approaches to minimize errors. | Lipids | 1987 | https://conductscience.org/library/papers/3613872 | PubMed |
| 7 | 1,580,550 | Requirement for mevalonate in the control of proliferation of human breast cancer cells. | Anticancer Res | 1992 | https://conductscience.org/library/papers/1580550 | PubMed |
| 8 | 1,352,323 | Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression. | J Lipid Res | 1992 | https://conductscience.org/library/papers/1352323 | PubMed |
| 9 | 7,658,148 | Regulatory effects of n-3 polyunsaturated fatty acids on hepatic LDL uptake in the hamster and rat. | J Lipid Res | 1995 | https://conductscience.org/library/papers/7658148 | PubMed |
| 10 | 3,841,001 | Variation in susceptibility to atherosclerosis among inbred strains of mice. | Atherosclerosis | 1985 | https://conductscience.org/library/papers/3841001 | PubMed |
| 11 | 291,922 | Essential role for mevalonate synthesis in DNA replication. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/291922 | PubMed |
| 12 | 8,349,823 | Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8349823 | PubMed |
| 13 | 6,768,732 | Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor. | J Biol Chem | 1980 | https://conductscience.org/library/papers/6768732 | PubMed |
| 14 | 9,288,773 | Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids. | Cancer Res | 1997 | https://conductscience.org/library/papers/9288773 | PubMed |
| 15 | 3,546,288 | Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. | J Biol Chem | 1987 | https://conductscience.org/library/papers/3546288 | PubMed |
| 16 | 6,995,544 | Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. | J Lipid Res | 1980 | https://conductscience.org/library/papers/6995544 | PubMed |
| 17 | 8,105,015 | Regulatory effects of individual n-6 and n-3 polyunsaturated fatty acids on LDL transport in the rat. | J Lipid Res | 1993 | https://conductscience.org/library/papers/8105015 | PubMed |
| 18 | 8,369,151 | Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. | Annu Rev Nutr | 1993 | https://conductscience.org/library/papers/8369151 | PubMed |
| 19 | 8,182,121 | Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. | J Clin Invest | 1994 | https://conductscience.org/library/papers/8182121 | PubMed |
| 20 | 2,369,897 | Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. | EMBO J | 1990 | https://conductscience.org/library/papers/2369897 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,221,836 | Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management. | EXCLI J | 2022 | https://conductscience.org/library/papers/35221836 | PubMed |
| 27,101,827 | Evaluation of the effect of n-3 PUFA-rich dietary fish oils on lipid profile and membrane fluidity in alloxan-induced diabetic mice (Mus musculus). | Mol Cell Biochem | 2016 | https://conductscience.org/library/papers/27101827 | PubMed |
| 20,042,103 | Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. | Lipids Health Dis | 2009 | https://conductscience.org/library/papers/20042103 | PubMed |
| 19,664,246 | Are all n-3 polyunsaturated fatty acids created equal? | Lipids Health Dis | 2009 | https://conductscience.org/library/papers/19664246 | PubMed |
| 18,922,179 | Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. | Lipids Health Dis | 2008 | https://conductscience.org/library/papers/18922179 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10580331
GET https://conductscience.org/api/papers/v1/10580331/references?page=2